ONE Bio Corp. (ONBI)

OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: May 2, 2025
Market Cap1.67K
Revenue (ttm)53.91M
Net Income (ttm)8.94M
Shares Out8.37M
EPS (ttm)1.22
PE Ratio0.00
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,100
Average Volumen/a
Open0.0002
Previous Closen/a
Day's Range0.0002 - 0.0002
52-Week Range0.0002 - 0.0002
Beta-4.38
RSIn/a
Earnings Daten/a

About ONE Bio

ONE Bio Corp., an agritech company, together with its subsidiaries, utilizes green process manufacturing to produce raw chemicals and herbal extracts, natural supplements, and organic products. The company operates through two business units, Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE business unit engages in the development, manufacture, and commercialization of bio-ecological products and over-the-counter products utilizing the extractions of tobacco leaves and various other plant materials. It produces chemical and... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 358
Stock Exchange OTCMKTS
Ticker Symbol ONBI
Full Company Profile

Financial Performance

In 2010, ONE Bio's revenue was $52.30 million, an increase of 136.92% compared to the previous year's $22.07 million. Earnings were $8.68 million, an increase of 81.79%.

Financial Statements

News

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal

Jiangsu Hengrui Pharma out-licensed global rights for an anti-inflammatory drug to ONE Bio in a $1 billion deal. Shanghai Sangon Biotech raised $290 million in funding from private investors. Hangzhou...

2 years ago - Seeking Alpha